Screening Assay for Enzymes Involved in Pathophysiology Using SELDI-TOF Mass Spectrometr

Khalid M. Elased, Mariana Morris

Research output: Other contribution

Abstract

The invention provides methods for quantifying enzymatic activity of an enzyme with a known substrate. The methods employ SELDI-TOF mass spectrometry, and are suitable, in particular, for assaying aspects of the renin-angiotensin system. The methods may be utilized to assess and/or monitor biological conditions associated with the renin-angiotensin system prior to the manifestation of known physiological and biomarkers for such conditions. The methods are suitable for analysis of pharmacological effectors of the renin-angiotensin system, and are particularly suitable for automation and high-throughput screening assay design.

Original languageAmerican English
StatePublished - Feb 19 2008

Keywords

  • Enzymes
  • Mass Spectrometry
  • Patents
  • SELDI-TOF
  • Screening assay
  • US7332296 B2

Disciplines

  • Chemicals and Drugs
  • Medical Toxicology
  • Medicine and Health Sciences

Cite this